KC-125ML-BK
Anti-E (clone MS-12), FFMU
Anti-E from the clone MS-12, Human IgM, Intermediate for further manufacturing use
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
biological source
human
Quality Level
antibody form
unpurified
clone
MS-12, monoclonal
form
liquid
packaging
pkg of 125 mL
concentration
2-15 mg/mL protein (Total Protein Range)
technique(s)
agglutination assay: suitable
pH
6.7-7.7
isotype
IgM
shipped in
ambient
storage temp.
2-8°C
Related Categories
General description
Standardized, concentrated cell culture supernatant which has been diafiltered with phosphate buffered saline.
For the formulation of Anti-E blood typing reagents or devices.
Contains 0.1% (w/v) Sodium Azide; Shelf Life: 24 months from date of filtration.
Licensed by the US FDA under a shared manufacturing agreement.
For the formulation of Anti-E blood typing reagents or devices.
Contains 0.1% (w/v) Sodium Azide; Shelf Life: 24 months from date of filtration.
Licensed by the US FDA under a shared manufacturing agreement.
Application
Antibody intermediate for further manufacturing use
Production of an in vitro blood typing product or device
Disclaimer
Partially processed reagent for further manufacture of non-injectable products only. The absence of all viral antigens has not been determined. No US Standard of Potency. Do not use if turbid. Contains 0.1% (w/v) sodium azide.
Storage Class
12 - Non Combustible Liquids
wgk_germany
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service